← Back to Clinical Trials
Recruiting NCT05072119

NCT05072119 Monaldi Hospital Rhythm Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05072119
Status Recruiting
Phase
Sponsor University of Campania Luigi Vanvitelli
Condition Pacemaker
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2015-01-07
Primary Completion 2030-01-07

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Device implantation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,000 participants in total. It began in 2015-01-07 with a primary completion date of 2030-01-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study is a prospective registry. Consecutive patients with indications of implant / replacement or upgrade of pacemaker (PM), implantable cardioverter defibrillator (ICD), Implanted loop recorder (ILR) will be enrolled. The primary objective of the study is to describe the clinical events during a long-term follow-up of non-selected population of patients implanted with an PM, ICD or ILR.

Eligibility Criteria

Inclusion Criteria: * All consecutive patients underwent PM/ICD/ILR implantation * Patient is willing and able to sign an authorization to use and disclose health information or an Informed Consent * Patient must be able to attend all required follow-up visits at the study center for at least 12 months Exclusion Criteria: * No informed consent * Patient is participating in another clinical study that may have an impact on the study endpoint Exclusion Criteria: * No informed consent

Contact & Investigator

Central Contact

Vincenzo Russo, MD PhD

✉ vincenzo.russo@unicampania.it

📞 +390817062355

Principal Investigator

Vincenzo Russo, MD PhD

STUDY CHAIR

University of Campania Luigi Vanvitelli

Frequently Asked Questions

Who can join the NCT05072119 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, studying Pacemaker. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05072119 currently recruiting?

Yes, NCT05072119 is actively recruiting participants. Contact the research team at vincenzo.russo@unicampania.it for enrollment information.

Where is the NCT05072119 trial being conducted?

This trial is being conducted at Naples, Italy.

Who is sponsoring the NCT05072119 clinical trial?

NCT05072119 is sponsored by University of Campania Luigi Vanvitelli. The principal investigator is Vincenzo Russo, MD PhD at University of Campania Luigi Vanvitelli. The trial plans to enroll 5,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology